NCT06961006View on ClinicalTrials.gov

A Clinical Study of V940 and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)

PHASE2RecruitingINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

May 29, 2025

Primary Completion Date

July 22, 2028

Study Completion Date

September 5, 2031

Conditions
Malignant Melanoma
Interventions
BIOLOGICAL

V940

IM injection

BIOLOGICAL

Pembrolizumab

IV infusion

OTHER

Placebo

IM injection

Trial Locations (30)

1023

RECRUITING

Harbour Cancer & Wellness ( Site 3040), Auckland

2065

RECRUITING

Melanoma Institute Australia ( Site 2000), Wollstonecraft

2148

RECRUITING

Blacktown Hospital ( Site 2001), Blacktown

6009

RECRUITING

One Clinical Research ( Site 2002), Nedlands

18547

RECRUITING

Metropolitan Hospital ( Site 2082), Athens

20133

RECRUITING

Fondazione IRCCS Istituto Nazionale dei Tumori di Milano ( Site 3021), Milan

20251

RECRUITING

Universitaetsklinikum Hamburg-Eppendorf ( Site 2060), Hamburg

22031

RECRUITING

Inova Schar Cancer Institute ( Site 4046), Fairfax

28034

RECRUITING

Hospital Universitario Ramón y Cajal-Medical Oncology ( Site 3082), Madrid

50937

RECRUITING

Universitaetsklinikum Koeln ( Site 2064), Cologne

69120

RECRUITING

NCT ( Site 2065), Heidelberg

72762

RECRUITING

Highlands Oncology Group ( Site 4042), Springdale

75010

RECRUITING

Hôpital Saint-Louis ( Site 2041), Paris

80131

RECRUITING

Istituto Nazionale Tumori IRCCS Fondazione Pascale ( Site 3020), Napoli

94143

RECRUITING

UCSF Helen Diller Medical Center at Parnassus Heights ( Site 4044), San Francisco

94800

RECRUITING

Gustave Roussy ( Site 2040), Villejuif

98109

RECRUITING

Fred Hutchinson Cancer Center ( Site 4041), Seattle

1834111

RECRUITING

Emek Medical Center ( Site 3003), Afula

4941492

RECRUITING

Rabin Medical Center ( Site 3002), Petah Tikva

5265601

RECRUITING

Sheba Medical Center ( Site 3000), Ramat Gan

9112001

RECRUITING

Hadassah Medical Center ( Site 3001), Jerusalem

07601

RECRUITING

John Theurer Cancer Center at Hackensack University Medical Center ( Site 4047), Hackensack

06202

RECRUITING

Centre Hospitalier Universitaire de Nice - Hôpital l'Archet-Dermatology Department ( Site 2042), Nice

570 01

RECRUITING

European Interbalkan Medical Center ( Site 2081), Thessaloniki

02-781

RECRUITING

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie ( Site 3060), Warsaw

1449-005

RECRUITING

Unidade Local de Saude Lisboa Ocidental - Hospital de São Francisco Xavier ( Site 4002), Lisbon

1649-035

RECRUITING

Unidade Local de Saude de Santa Maria - Hospital de Santa Maria ( Site 4001), Lisbon

4200-072

RECRUITING

Instituto Português de Oncologia do Porto Francisco Gentil, EPE ( Site 4000), Porto

08035

RECRUITING

Hospital Universitari Vall d'Hebron ( Site 3081), Barcelona

08036

RECRUITING

Hospital Clínic Barcelona ( Site 3080), Barcelona

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY